Cargando…

Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study

BACKGROUND: Despite recent intensification of control measures, Plasmodium vivax poses a major challenge for malaria elimination efforts. Liver-stage hypnozoite parasites that cause relapsing infections can be cleared with primaquine; however, poor treatment adherence undermines drug effectiveness....

Descripción completa

Detalles Bibliográficos
Autores principales:	Nekkab, Narimane, Lana, Raquel, Lacerda, Marcus, Obadia, Thomas, Siqueira, André, Monteiro, Wuelton, Villela, Daniel, Mueller, Ivo, White, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064585/ https://www.ncbi.nlm.nih.gov/pubmed/33891582 http://dx.doi.org/10.1371/journal.pmed.1003535

Ejemplares similares

Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil
por: Nekkab, Narimane, et al.
Publicado: (2023)

The top 1%: quantifying the unequal distribution of malaria in Brazil
por: Lana, Raquel, et al.
Publicado: (2021)

Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment
por: Obadia, Thomas, et al.
Publicado: (2022)

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
por: Beck, Hans-Peter, et al.
Publicado: (2016)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
por: Lacerda, M.V.G., et al.
Publicado: (2019)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Plasmodium vivax malaria elimination: should innovative ideas from the past be revisited?
por: Val, Fernando Fonseca, et al.
Publicado: (2014)

Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
por: Sharma, Jatin, et al.
Publicado: (2021)

Short-Time Recurrences of Plasmodium vivax Malaria as a Public Health Proxy for Chloroquine-Resistance Surveillance: A Spatio-Temporal Study in the Brazilian Amazon
por: Balieiro, Antonio A. S., et al.
Publicado: (2021)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
por: Watson, James A, et al.
Publicado: (2022)

Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand
por: He, Wen-Qiang, et al.
Publicado: (2019)

Plasmodium vivax molecular diagnostics in community surveys: pitfalls and solutions
por: Gruenberg, Maria, et al.
Publicado: (2018)

Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivax
por: Rosado, Jason, et al.
Publicado: (2022)

The spatial signature of Plasmodium vivax and Plasmodium falciparum infections: quantifying the clustering of infections in cross-sectional surveys and cohort studies
por: Sandfort, Mirco, et al.
Publicado: (2023)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
por: Duparc, Stephan, et al.
Publicado: (2020)

Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
por: Suh, Jiyeon, et al.
Publicado: (2022)

How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites
por: Huber, John H., et al.
Publicado: (2021)

Is zoonotic Plasmodium vivax malaria an obstacle for disease elimination?
por: Chaves, Bárbara Aparecida, et al.
Publicado: (2022)

Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensities
por: Koepfli, Cristian, et al.
Publicado: (2021)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
por: Ebstie, Yehenew A, et al.
Publicado: (2016)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
por: Markus, Miles B
Publicado: (2021)

Association of TLR variants with susceptibility to Plasmodium vivax malaria and parasitemia in the Amazon region of Brazil
por: Costa, Allyson Guimarães, et al.
Publicado: (2017)

Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts
por: Rosado, Jason, et al.
Publicado: (2021)

Are respiratory complications of Plasmodium vivax malaria an underestimated problem?
por: Val, Fernando, et al.
Publicado: (2017)

Plasmodium vivax Landscape in Brazil: Scenario and Challenges
por: Siqueira, Andre M., et al.
Publicado: (2016)

Key Knowledge Gaps for Plasmodium vivax Control and Elimination
por: Bassat, Quique, et al.
Publicado: (2016)

Cardiovascular changes in patients with non-severe Plasmodium vivax malaria()
por: Alencar-Filho, Aristoteles Comte, et al.
Publicado: (2016)

Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination
por: Recht, Judith, et al.
Publicado: (2017)

Utility of ultra-sensitive qPCR to detect Plasmodium falciparum and Plasmodium vivax infections under different transmission intensities
por: Gruenberg, Maria, et al.
Publicado: (2020)

Thrombocytopenia in Plasmodium vivax Malaria Is Related to Platelets Phagocytosis
por: Coelho, Helena Cristina C., et al.
Publicado: (2013)

Viability and Infectivity of Plasmodium vivax Gametocytes in Short-Term Culture
por: Ramos, Glenda Quaresma, et al.
Publicado: (2021)

Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set
por: Sharma, Raman, et al.
Publicado: (2023)

Implications of Plasmodium vivax Biology for Control, Elimination, and Research
por: Olliaro, Piero L., et al.
Publicado: (2016)

Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi
por: Longley, Rhea J., et al.
Publicado: (2022)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria
por: Mayence, Annie, et al.
Publicado: (2019)

Micronutrient Deficiencies and Plasmodium vivax Malaria among Children in the Brazilian Amazon
por: Benzecry, Silvana Gomes, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j3pbo7urv2bimn93ph8vvjqjrt